Parkinson's Disease News and Research

RSS
Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.
Newly developed stem cell technologies show promise for treating PD patients

Newly developed stem cell technologies show promise for treating PD patients

Rapid progression of age-related diseases may result from formation of vicious cycles

Rapid progression of age-related diseases may result from formation of vicious cycles

Experts explore involvement of the gut in Parkinson's disease

Experts explore involvement of the gut in Parkinson's disease

New neurofeedback system enables Parkinson's patients to voluntarily control brain waves

New neurofeedback system enables Parkinson's patients to voluntarily control brain waves

Beta wave control in Parkinson’s diseased brain could be a potential therapy

Beta wave control in Parkinson’s diseased brain could be a potential therapy

Neurofeedback system enables Parkinson's patients to voluntarily control brain wave activity

Neurofeedback system enables Parkinson's patients to voluntarily control brain wave activity

Understanding ‘prodromal’ phase in Parkinson’s may prevent disease from developing

Understanding ‘prodromal’ phase in Parkinson’s may prevent disease from developing

Researchers identify blood-based biomarkers of Parkinson's disease

Researchers identify blood-based biomarkers of Parkinson's disease

Newron announces successful completion of patient enrollment in STARS study

Newron announces successful completion of patient enrollment in STARS study

A new step in decoding cell-to-cell communication

A new step in decoding cell-to-cell communication

Insilico to present its latest results in AI for Drug Discovery on CXOTalk Show

Insilico to present its latest results in AI for Drug Discovery on CXOTalk Show

Experts highlight emerging evidence of impending Parkinson’s disease pandemic

Experts highlight emerging evidence of impending Parkinson’s disease pandemic

Insilico Medicine to present latest advances in aging biomarker development at Longevity Leaders Conference

Insilico Medicine to present latest advances in aging biomarker development at Longevity Leaders Conference

Skin samples hold early signs of prion disease, research suggests

Skin samples hold early signs of prion disease, research suggests

Insilico to present latest findings in AI for Drug Discovery at 3rd Annual SABPA FTD Forum

Insilico to present latest findings in AI for Drug Discovery at 3rd Annual SABPA FTD Forum

MPFI researchers identify synaptic logic for connections between two brain hemispheres

MPFI researchers identify synaptic logic for connections between two brain hemispheres

Study shows how gut bacteria affect the treatment of Parkinson's disease

Study shows how gut bacteria affect the treatment of Parkinson's disease

Scientists develop new gene therapy that prevents axon destruction in mice

Scientists develop new gene therapy that prevents axon destruction in mice

Behavioral experiments confirm that additional neurons improve brain function

Behavioral experiments confirm that additional neurons improve brain function

Smoking significantly increases your biological age, study shows

Smoking significantly increases your biological age, study shows